Biosouthwest 2006 Focuses on Regional Strengths, Arizona BioIndustry Will Benefit Everyday Lives

Share Article

BioSouthwest 2006, the premier biotech and bioscience conference with a regional focus is April 3 & 4 in Tucson. The region’s latest crop of startups and maturing companies will be featured as they respond to issues of our times.

BioSouthwest 2006, the premier biotech and bioscience conference with a Southwestern regional focus, is April 3 & 4 in Tucson. The region’s latest crop of startups and maturing companies will be featured as they respond to the issues of our times. The consequences of an aging baby boomer generation, bioterrorism such as the Anthrax attacks post 9/11, and emerging infectious threats have all inspired diverse innovations.

While addressing the needs of aging populations, cutting-edge bioengineering will be presented. Exciting stem cell therapeutic approaches also will be described by Cord Blood Registry and Vet-Stem. This will provide an opportunity to learn about somatic stem cell sources and veterinary applications of cellular materials in regenerative medicine. The subject is so important to the region’s biotech scene, that the organizers have arranged a free, one day symposium on April 5 devoted to Stem Cells. More information about that special focus meeting is available at http://www.bio-sa.org.

The insecurities of modern life also are addressed at BioSouthwest. Virus Like Particle-based technology of Virionics provides a means to respond to health concerns over Avian Flu, Ebola and West Nile Virus. The threat of bioterrorism also is confronted by Ribomed, which is commercializing novel, portable and rapid pathogen detection devices. Beyond germ warfare, however, Ribomed’s technology, along with Ventana Medical System’s platform and diagnostics kits work towards improved quality of patient care. Both companies may help realize the promise of personalized medical care.

Both the conditions of aging, and the massive casualties of war such as in Iraq and Afganistan, will drive the need for chronic pain management. Drawing inspiration from the brain’s ability to blunt pain through endorphins, Dr. Robin Polt will describe new analgesic drug candidates that lack the adverse liabilities of traditional opiates.

Maturing biocompanies include the cancer-fighting company AmpliMed and clot busting company ImaRx. AmpliMed and ImaRx were founded by successful serial biomedical entrepreneurs, Drs. Evan Hersh and Evan Unger, respectively.

BioSouthwest 2006 is the most complete biotech and biosciences conference for the year focusing on regional strengths. The business tone for the meeting will be set by G. Steven Burrill, of Burrill & Co of San Francisco. Renowned plant geneticist Vicki Chandler, Director of Bio5 at the University of Arizona, will provide the luncheon plenary lecture, describing her vision of translational research bringing benefits to people’s everyday lives. The remainder of the agenda has scientific and business tracks on April 4, and an exhibition hall is open to the public on the first day, April 3. The conference runs all day on April 4, and more information is available at the hosting organization’s website – http://www.bio-sa.org. The conference is hosted by the BioIndustry Organization of Southern Arizona, a nonprofit trade organization committed to promoting bioindustry in the region through community building and business enablement.

BioSouthwest 2006 and BIO-SA CONTACT:

David Thorpe, MD PhD

Chair, BIOSA

Dept. of Discovery Biology

Sanofi-Aventis Combinatorial Technologies Center

Telephone: (520) 544 - 5842

FAX: (520) 575 - 8283

MEDIA CONTACT:

Sandra Kay Helsel, Ph.D.

SK Helsel & Associates

http://www.skhelsel.com

# # #

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Sandra Helsel
Visit website